Luteinizing hormone and follicle stimulating hormone for use in inducing folliculogenesis
View Patent ↗The present invention relates to the use of gonadotrophins in the induction of folliculogenesis in anovulatory women. In particular, it relates to the use of LH (or an equivalent dosage of hCG) in the production of a medicament for inducing folliculogenesis in anovulatory women at a specified daily doses. In certain embodiments, LH may be used in conjunction with FSH.
1. A product containing packaged LH or an equivalent dose of hCG, and packaged FSH and/or an equivalent dose of a biologically-active analogue thereof, at an IU ratio of LH:FSH of about 10:1 or an equivalent ratio of hCG and/or analogue of FSH, combined in a kit for simultaneous, sequential or separate use in inducing paucifolliculogenesis or unifolliculogenesis in women.
2. A product as claimed in claim 1 , which comprises 375 IU of r-hLH, or an equivalent dose of hCG, and 37.5 IU of r-hFSH.